Radiopharmaceutical Medical Science Liaison (RPT-MSL)

RayzeBio is a dynamic biotechnology company headquartered in San Diego, CA. Launched in late 2020 and recently acquired by Bristol Myers Squibb (BMS) as a wholly owned subsidiary, the company is focused on improving survival of people with cancer by harnessing the power of targeted radioisotopes. RayzeBio will operate as a standalone entity within the BMS organization, maintaining its biotech culture with the opportunity to leverage the best-in-class oncology capabilities of BMS. RayzeBio is developing innovative drugs against targets of solid tumors. The lead asset, RYZ101, is in Phase 3 testing for patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs).

We are seeking a Radiopharmaceutical Medical Science Liaison (RPT-MSL) for RayzeBio to be trusted agile partner to the Thought Leader community. The role will engage in authentic, peer-to-peer scientific dialogue with leading RPT Thought Leaders and HCPs to strengthen RayzeBio’s scientific leadership, accelerat...